Feline Cutaneous Squamous Cell Carcinoma (Non-Oral / Solar-Induced)

Feline cutaneous squamous cell carcinoma (SCC) of non-oral, solar-induced origin is a malignant neoplasm arising from the epidermal keratinocytes of the skin, most commonly triggered by chronic ultraviolet (UV) radiation exposure. It is one of the most frequently diagnosed skin tumors in cats and predominantly affects lightly pigmented, white-furred, or sparsely haired regions of the body. Unlike oral SCC in cats, solar-induced cutaneous SCC tends to be locally aggressive but carries a comparatively more favorable prognosis when detected and treated early. The disease follows a well-recognized progression from solar (actinic) dermatitis and carcinoma in situ (Bowen-like disease precursors) through to invasive carcinoma.

Primary Cause: Ultraviolet Radiation The fundamental cause of solar-induced feline cutaneous SCC is chronic, cumulative exposure to UV radiation, particularly UVB (wavelengths 280–315 nm). UV radiation directly damages keratinocyte DNA, most notably through the formation of cyclobutane pyrimidine dimers and 6-4 photoproducts within the DNA strand. When these mutations are not adequately repaired, they cause characteristic "UV signature" mutations, particularly in the tumor suppressor gene TP53 (p53). Inactivation of p53 removes a critical checkpoint in the cell cycle, allowing genomically damaged cells to proliferate rather than undergo apoptosis, driving clonal expansion and malignant transformation.

Risk Factors

• ·Coat color and pigmentation: White-coated or lightly pigmented cats are at dramatically higher risk because melanin in the epidermis absorbs UV radiation and provides photoprotection. Cats with white ears, white noses, or predominantly white coats are the most susceptible.
• ·Geographic and environmental factors: Cats living at high altitudes, in regions with high annual sun exposure (e.g., Australia, the American Southwest, Mediterranean climates), or those spending significant time outdoors or near sun-reflecting surfaces (e.g., snow, sand, glass) have elevated lifetime UV exposure.
• ·Age: The disease is age-related, as cumulative UV damage accumulates over years; most affected cats are middle-aged to geriatric (>8 years).
• ·Anatomic sites: The nasal planum, ear tips (pinnae), and eyelids are the most commonly affected because they lack protective hair coverage, have sparse or absent melanin, and are directly exposed to incident sunlight.

Pathological Progression The disease typically progresses through recognizable pre-malignant stages. Chronic UV exposure initially induces solar (actinic) dermatitis, characterized histologically by epidermal dysplasia, dyskeratosis, and dermal solar elastosis. This progresses to carcinoma in situ (also called Bowen's disease or intraepidermal carcinoma in cats), where full-thickness epidermal dysplasia is present but the basement membrane remains intact. Ultimately, invasive SCC develops when malignant keratinocytes breach the basement membrane and infiltrate the dermis. Invasive SCC can eventually spread to regional lymph nodes (primarily the mandibular and parotid nodes for head lesions) and, less commonly, to distant sites such as the lungs, though metastasis is considerably less frequent with solar-induced cutaneous SCC than with oral SCC in cats.

Clinical Examination Diagnosis begins with a thorough physical examination of the skin, with particular attention to the nasal planum, pinnae, eyelids, and other sun-exposed sites. Any non-healing ulceration, plaque, or erosion in a white or lightly pigmented cat, especially one aged over 8 years, should be considered suspicious for SCC until proven otherwise. The distribution and character of lesions (ulcerated, crusted, erythematous plaques on actinic-damaged skin) are often strongly suggestive.

Cytology Fine-needle aspiration (FNA) of lesion tissue or impression smears from ulcerated surfaces may reveal large, pleomorphic squamous cells with atypical nuclei, prominent nucleoli, and sometimes keratin pearls. Cytology is a useful screening tool but cannot definitively assess invasiveness or confirm histologic grade.

Histopathology (Definitive Diagnosis) Biopsy and histopathological examination of tissue is the gold standard for diagnosis. A full-thickness skin biopsy (punch, incisional, or excisional) is required to distinguish carcinoma in situ from invasive SCC. Pathologic findings include nests and cords of atypical squamous epithelial cells invading the dermis, individual cell keratinization, keratin pearls, intercellular bridges, and varying degrees of differentiation (well-, moderately-, or poorly-differentiated). The degree of differentiation and depth of invasion carry prognostic importance.

Staging and Imaging Once SCC is confirmed, clinical staging is recommended:

• ·Regional lymph node assessment: Palpation and FNA or biopsy of the mandibular/parotid lymph nodes (for facial lesions) to evaluate for regional metastasis.
• ·Thoracic radiographs (three views): To screen for pulmonary metastasis; should be performed in all confirmed SCC cases before definitive treatment.
• ·Advanced imaging (CT scan): Computed tomography of the head and thorax provides superior detail for evaluating tumor extent, bone involvement (e.g., nasal bone), and lymph node status, and is increasingly recommended prior to surgery or radiation therapy planning.

Laboratory Findings While there are no pathognomonic blood abnormalities for cutaneous SCC, a complete blood count (CBC), serum chemistry panel, and urinalysis are recommended as part of preoperative workup, especially in older cats:

• ·Complete Blood Count (CBC): May show a mild normocytic, normochromic anemia (↓ HCT/PCV) due to chronic disease or blood loss from ulcerated tumors; leukocytosis (↑ WBC) may be present with secondary bacterial infection
• ·Serum Chemistry:
  • ·ALB (albumin): May be low in cats with significant chronic inflammation, blood loss, or poor nutritional intake due to facial pain
  • ·GLOB (globulins): May be elevated due to chronic antigenic stimulation and inflammation
  • ·ALT: Occasionally mildly elevated in older cats with concurrent hepatic disease (not tumor-specific)
  • ·BUN/CREA: Important to evaluate for concurrent chronic kidney disease (CKD), which is common in the geriatric cat population and significantly influences anesthetic and treatment decisions
  • ·TBIL: Generally within normal limits unless concurrent hepatic disease is present
• ·PLT (platelets): Usually normal; thrombocytopenia would be unexpected unless paraneoplastic or bone marrow involvement (rare)

Surgery Surgical excision with wide, clean margins remains the first-line and most curative treatment for localized cutaneous SCC. Specific surgical approaches depend on anatomic location:

• ·Nasal planum: Nasal planum resection (nosectomy) achieves wide margins and is well-tolerated by cats; studies report excellent local control rates with this approach, and cosmetic outcomes are generally accepted by owners.
• ·Pinnae (ear tips): Pinnectomy (partial or total ear tip resection) is effective for early lesions confined to the ear tip and is associated with good local control rates.
• ·Eyelid lesions: Partial or full eyelid resection may be necessary; reconstructive techniques are often required to preserve ocular function.
• ·Histopathologic margin assessment is essential; incomplete excision significantly increases local recurrence risk.

Radiation Therapy Radiation therapy (RT) is indicated when surgical excision is not possible (e.g., extensive disease, poor patient condition) or as adjuvant therapy following incomplete resection. Both orthovoltage and megavoltage radiation and strontium-90 (Sr-90) plesiotherapy (surface radiation) have been used. Sr-90 plesiotherapy is particularly useful for superficial, carcinoma in situ lesions or early invasive SCC and is reported to achieve good local control for small superficial tumors.

Photodynamic Therapy (PDT) PDT involves the administration of a photosensitizing agent (e.g., 5-aminolevulinic acid [ALA]) followed by activation with specific wavelengths of light at the tumor site, generating reactive oxygen species that destroy tumor cells. PDT has been reported as an effective alternative or adjunct treatment for superficial cutaneous SCC lesions, particularly carcinoma in situ and very early invasive disease, though it is less effective for thicker or deeply invasive lesions.

Cryotherapy Cryotherapy (liquid nitrogen application) is an option for small, superficial lesions or carcinoma in situ. Multiple freeze-thaw cycles are applied to ensure adequate tissue destruction. It is most effective for lesions <1 cm in diameter and is associated with lower local control rates than surgery for invasive SCC.

Medical and Systemic Therapies

• ·Retinoids: Synthetic vitamin A derivatives (e.g., isotretinoin, etretinate) have been used to slow progression of actinic keratosis and carcinoma in situ, though clinical evidence in cats is limited and these agents are not curative for invasive SCC.
• ·NSAIDs / COX-2 inhibitors: Cyclooxygenase-2 (COX-2) is overexpressed in feline SCC. NSAIDs such as meloxicam have been used as part of palliative or adjunctive protocols, with potential antiproliferative effects, though their role as primary treatment agents is supportive rather than curative.
• ·Chemotherapy: Systemic chemotherapy (e.g., carboplatin, bleomycin) has been used for metastatic or unresectable SCC; intralesional carboplatin or cisplatin formulations have been used for local tumor control. Response rates are variable, and chemotherapy is generally considered palliative in this context.
• ·Toceranib phosphate (Palladia): This receptor tyrosine kinase inhibitor has been used as part of multimodal protocols for feline SCC, though evidence specific to cutaneous solar-induced SCC remains limited.

Supportive Care

• ·Pain management with opioids, gabapentin, or NSAIDs (with appropriate renal monitoring)
• ·Antibiotics for secondary bacterial infections of ulcerated lesions
• ·Nutritional support in cats with significant facial involvement affecting eating
• ·Elizabethan collars to prevent self-trauma to active lesions

General Prognosis The prognosis for feline solar-induced cutaneous SCC is significantly more favorable than for feline oral SCC and depends heavily on the stage at diagnosis, anatomic location, and treatment modality employed. Early-stage, localized disease treated with aggressive surgical excision or appropriate local therapy carries a good to excellent prognosis for long-term local control.

Site-Specific Outcomes

• ·Nasal planum SCC: Nosectomy (surgical resection) is associated with median survival times reported in the range of 1.5–2+ years post-surgery in several case series, with many cats achieving prolonged disease-free intervals. Local recurrence is the primary concern; distant metastasis is uncommon at presentation for localized disease.
• ·Pinnal SCC: Pinnectomy for early pinnal lesions generally carries a favorable prognosis with good local control. The prognosis worsens significantly if disease extends beyond the pinna to auricular cartilage or surrounding tissues.
• ·Carcinoma in situ (Bowen-like lesions): Because the basement membrane is intact, these lesions have an excellent prognosis with appropriate local treatment; however, cats with multicentric carcinoma in situ lesions require lifelong monitoring for new lesion development.

Factors Affecting Prognosis

• ·Stage at diagnosis: Early-stage disease (small, non-invasive or superficially invasive tumors without lymph node or distant metastasis) carries a significantly better prognosis than advanced disease.
• ·Surgical margin status: Complete excision with clean histologic margins is the single most important prognostic variable; incomplete margins are associated with higher recurrence rates.
• ·Regional lymph node involvement: Metastasis to regional lymph nodes substantially worsens prognosis and is associated with shorter survival.
• ·Tumor grade: Well-differentiated SCCs tend to behave less aggressively than poorly differentiated tumors, though all invasive SCC should be treated definitively.
• ·Multiplicity of lesions: Cats with involvement at multiple sites simultaneously require more aggressive monitoring and treatment planning.

Mortality Context Solar-induced cutaneous SCC can be a progressive, ultimately life-limiting disease if left untreated or if disease is advanced at diagnosis. However, the overall mortality rate for the disease treated with appropriate early intervention is substantially lower than for feline oral SCC (which carries median survival times of only 1–3 months). Cats with surgically managed, localized nasal or pinnal SCC commonly survive 2 or more years post-treatment, and some are long-term survivors. The primary cause of death or euthanasia is typically local tumor progression and associated disfigurement/pain, rather than systemic metastatic disease.

UV Exposure Reduction The most effective preventive strategy is limiting UV radiation exposure, particularly in at-risk white or lightly pigmented cats:

• ·Indoor confinement: Keeping susceptible cats indoors, especially during peak UV hours (10 AM–4 PM), dramatically reduces cumulative UV exposure over a lifetime.
• ·UV-blocking window film: Applying UV-protective film to windows can significantly reduce UV penetration for cats that spend time near windows indoors.
• ·Limited outdoor access: If outdoor access is provided, cats should have access to shaded areas and be kept indoors during peak sunlight hours.

Topical Sunscreen Application of pet-safe, zinc-free topical sunscreens (with SPF 30 or higher) to the nasal planum, ear tips, and periocular regions has been recommended for white cats with outdoor lifestyles. Importantly, human sunscreens containing zinc oxide or salicylates must be avoided as they are toxic to cats if ingested during grooming. Only veterinarian-approved formulations should be used, and practical compliance is often a challenge.

Early Detection and Monitoring

• ·Regular veterinary dermatologic examinations (every 6–12 months) for at-risk cats (white coat, outdoor lifestyle, geriatric age) to detect pre-malignant actinic lesions or carcinoma in situ before progression to invasive SCC
• ·Owner education about the early warning signs of actinic keratosis (crusting, erythema, alopecia on sun-exposed areas) and the importance of prompt veterinary evaluation
• ·Biopsy of any persistent, non-healing lesion rather than prolonged empirical treatment with antibiotics or antifungals

No Available Vaccine There is currently no vaccine available for the prevention of feline cutaneous SCC. Prevention relies entirely on lifestyle management and UV exposure reduction.